DAKKUKAI

This brand name is authorized in Hong Kong SAR China.

Active ingredients

The drug DAKKUKAI contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 213N3S8275 - CAMPHOR, (-)-
 
Read more about Camphora
2
UNII P540XA09DR - ENOXOLONE
 

Enoxolone is a pentacyclic triterpenoid aglycone metabolite of glycyrrhizin, which is a product of the plant Glycyrrhiza glabra (licorice), with potential expectorant, and gastrokinetic activities. After administration, enoxolone inhibits the metabolism of prostaglandins by both 15-hydroxyprostaglandin dehydrogenase [NAD] and prostaglandin reductase 2.

 
Read more about Enoxolone
3
UNII BZ1R15MTK7 - LEVOMENTHOL
 
Read more about Menthol
4
UNII LAV5U5022Y - METHYL SALICYLATE
 

Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet.

 
Read more about Methyl salicylate
5
UNII 9E8X80D2L0 - .ALPHA.-TOCOPHEROL ACETATE
 

Vitamin E is known to exert an important physiological function as an antioxidant for fats, with a sparing action on vitamin A, carotenoids and on unsaturated fatty acids. Other work has demonstrated that vitamin E is connected with the maintenance of certain factors essential for the normal metabolic cycle.

 
Read more about Vitamin E

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
HK Department of Health Drug Office 66142

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.